by Zach Parton | May 17, 2018 | Science |
In 2016, Perlara and Wylder Nation launched a PerlQuest to find a cure for Niemann-Pick Type A (NPA). We have also been developing simple organism disease models for Niemann-Pick Type C (NPC) as a part of our research collaboration with Novartis. An interesting...
by Naz Dana | Apr 11, 2018 | Business |
As our team grows, we would like to take the time to introduce some of the newest Perlara scientists. Or, more accurately, we would like them to introduce themselves in their own words like our first scientific team did. Instead of an academic and professional bio...
by Ethan Perlstein | Feb 26, 2018 | Business |
Today is Perlara’s birthday — 4 years old! As the first biotech public benefit corporation (bioPBC) we embraced openness in business and science from the start. As part of that commitment to accountability, I’m pleased to share our 2017 Benefit...
by Ethan Perlstein | Nov 24, 2016 | Perlara science |
Two weeks ago we posted Perlara’s first preprint to bioRxiv, along with all the raw data on GitHub: Predicting the phenotype of Mendelian disease missense mutations using amino acid conservation and … https://t.co/PWBuYakkMI #bioRxiv — bioRxiv...
